Cerebrovascular pathology in cognitive impairment: New (in)sights

David S. Knopman

doi:10.1212/WNL.0b013e31824e8fb4

Cerebrovascular pathology in cognitive impairment: New (in)sights

David S. Knopman

Neurology

Research output: Contribution to journal › Editorial › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	1032-1033
Number of pages	2
Journal	Neurology
Volume	78
Issue number	14
DOIs	https://doi.org/10.1212/WNL.0b013e31824e8fb4
State	Published - Apr 3 2012

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e31824e8fb4

Cite this

@article{0edf11523ba149c19f1887f562af6031,

title = "Cerebrovascular pathology in cognitive impairment: New (in)sights",

author = "Knopman, {David S.}",

note = "Funding Information: Dr. Knopman serves as Deputy Editor for Neurology {\textregistered} ; serves on a data safety monitoring board for Eli Lilly and Company; is an investigator in clinical trials sponsored by Elan Corporation, Baxter International Inc., and Forest Laboratories, Inc.; and receives research support from the NIH. Funding Information: Study funding: Supported by NIH grants P50 AG16574, U01 AG06786, and R01 AG11378, and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation. ",

year = "2012",

month = apr,

day = "3",

doi = "10.1212/WNL.0b013e31824e8fb4",

language = "English (US)",

volume = "78",

pages = "1032--1033",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "14",

}

TY - JOUR

T1 - Cerebrovascular pathology in cognitive impairment

T2 - New (in)sights

AU - Knopman, David S.

N1 - Funding Information: Dr. Knopman serves as Deputy Editor for Neurology ® ; serves on a data safety monitoring board for Eli Lilly and Company; is an investigator in clinical trials sponsored by Elan Corporation, Baxter International Inc., and Forest Laboratories, Inc.; and receives research support from the NIH. Funding Information: Study funding: Supported by NIH grants P50 AG16574, U01 AG06786, and R01 AG11378, and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation.

PY - 2012/4/3

Y1 - 2012/4/3

UR - http://www.scopus.com/inward/record.url?scp=84860750249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860750249&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e31824e8fb4

DO - 10.1212/WNL.0b013e31824e8fb4

M3 - Editorial

C2 - 22377812

AN - SCOPUS:84860750249

VL - 78

SP - 1032

EP - 1033

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 14

ER -

Cerebrovascular pathology in cognitive impairment: New (in)sights

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this